03.05.2015 Views

Here - EWMA 2013

Here - EWMA 2013

Here - EWMA 2013

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

POSTER: CASE STUDY<br />

Poster: Case Study<br />

P 402<br />

PYODERMA GANGRENOSUM – STILL CHALLENGING IN DIAGNOSIS AND<br />

TREATMENT<br />

Cornelia Erfurt-Berge 1 , Juergen Bauerschmitz 1<br />

1 University Hospital Erlangen, Department of Dermatology (Erlangen, Germany).<br />

Aim: Pyoderma gangraenosum is a painful, ulcerating skin disease of unknown<br />

aetiology. Diagnosis is generally based on clinical signs and histological examination is<br />

nonspecific. Associations with numerous systemic diseases have been described in the<br />

literature. Due to pathergy surgical measures can provoke an increase of the ulcers.<br />

Methods: A 79-year-old woman was referred to our department for evaluation of chronic<br />

leg ulcers which first appeared in 2007 on the right dorsal and the left lateral lower leg.<br />

Before first admission to our clinic, the patient was treated by her general practitioner<br />

under the diagnosis of venous leg ulcers. Several surgical interventions did not show<br />

any effort. Taken together the clinical findings with two deep ulcerated lesions with<br />

raised and undermined borders and a medical history of ulcers recalcitrant to<br />

phlebosurgical interventions and failure of skin grafts the diagnosis of pyoderma<br />

gangrenosum was taken into account and an immunosuppressive treatment was<br />

started. No underlying disease associated with pyoderma gangrenosum was detected.<br />

Results: After immunosuppressive medication with corticosteroids and dapsone was<br />

started the progress of the ulcerations stopped and after sufficient granulation tissue had<br />

developed by negative pressure therapy the wounds were provided successfully with<br />

split-thickness skin grafts.<br />

Conclusions: Although the clinical findings in cases of pyoderma gangrenosum may be<br />

very clear, the diagnosis remains complicated since histological findings are imprecise<br />

and many other diseases with similar appearance have to be excluded at first. Not<br />

before the inflammation is stopped by immunosuppressive medication more invasive<br />

strategies like surgical interventions should be performed.<br />

P 403<br />

EVALUATION OF A SILVER PRODUCT IN WOUND MANAGEMENT<br />

Poster: Case Study<br />

Jane Preece 1<br />

1 Whittington Hospital (London, United Kingdom).<br />

Aim: This poster aims to present two case studies evaluating the use of a Silver Alginate<br />

Dressing*.<br />

Method: Patient A: A 67 year old male presented with a lower leg ulcer to his left leg<br />

after it had been healed for 2 years. The wound measured 10cm x 12cm the wound bed<br />

was covered with healthy granulation tissue, but there was a large amount of exudate<br />

and clinical signs of infection.<br />

Patient B: A female with a 5 year history of bilateral venous disease presented with<br />

ulcers on both lower legs. It was decided to use the silver alginate dressing* only on the<br />

right leg for a two week period, to compare the treatment results between the legs.<br />

Results: Patient A: The ionic silver dressing* was used for a 2 week period, this resulted<br />

in a reduction in exudate now been to a minimal and no clinical signs of infection. After a<br />

3 week period the wound was completely healed, the patient was very pleased with the<br />

result.<br />

Patient B: Within a 2 week period the wound on the right leg had reduced in size by<br />

50%. The use of the silver alginate dressing* had kick started healing, a clear difference<br />

was observed between the right and the left leg. The wound on the left leg made no<br />

improvement and stayed the same.<br />

Conclusion: Silver has been commonly used as part of wound management for several<br />

years. Recently the use of silver has been questioned, since evaluating this specific<br />

silver product and introducing a protocol for use, the author has seen positive results in<br />

the progression and healing of wounds.<br />

*B.Braun Medical, Askina Calgitrol Ag<br />

<strong>EWMA</strong> <strong>2013</strong><br />

COPENHAGEN<br />

15-17 May · <strong>2013</strong><br />

Danish Wound<br />

Healing Society<br />

231

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!